Last updated: 16 July 2019 at 5:05am EST

Roger C Lucas Net Worth




The estimated Net Worth of Roger C Lucas is at least $6.67 Million dollars as of 5 March 2019. Roger Lucas owns over 8,421 units of ChemoCentryx Inc stock worth over $5,316,861 and over the last 21 years Roger sold CCXI stock worth over $1,354,328.

Roger Lucas CCXI stock SEC Form 4 insiders trading

Roger has made over 57 trades of the ChemoCentryx Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Roger exercised 8,421 units of CCXI stock worth $437,808 on 5 March 2019.

The largest trade Roger's ever made was exercising 27,027 units of ChemoCentryx Inc stock on 21 May 2015 worth over $1,405,134. On average, Roger trades about 2,382 units every 29 days since 2003. As of 5 March 2019 Roger still owns at least 102,267 units of ChemoCentryx Inc stock.

You can see the complete history of Roger Lucas stock trades at the bottom of the page.



What's Roger Lucas's mailing address?

Roger's mailing address filed with the SEC is 41 EAST PLEASANT LAKE ROAD, , NORTH OAKS, MN, 55127.

Insiders trading at ChemoCentryx Inc

Over the last 13 years, insiders at ChemoCentryx Inc have traded over $355,980,520 worth of ChemoCentryx Inc stock and bought 3,166,975 units worth $19,475,662 . The most active insiders traders include Plc Gsk, Rishi Gupta, and (International) Ltd Vifor P.... On average, ChemoCentryx Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,175,785. The most recent stock trade was executed by Susan M Kanaya on 16 August 2022, trading 19,898 units of CCXI stock currently worth $216,092.



What does ChemoCentryx Inc do?

ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies. ChemoCentryx's lead drug candidate, avacopan (CCX168), successfully completed a pivotal Phase III trial in ANCA-associated vasculitis and a New Drug Application is under review by the U.S. Food and Drug Administration. Avacopan is also in late stage clinical development for the treatment of severe Hidradenitis Suppurativa and C3 glomerulopathy (C3G). ChemoCentryx also has early stage drug candidates that target chemoattractant receptors in other inflammatory and autoimmune diseases and in cancer.



What does ChemoCentryx Inc's logo look like?

ChemoCentryx Inc logo

Complete history of Roger Lucas stock trades at Bio-Techne Corp and ChemoCentryx Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
5 Mar 2019 Roger C Lucas
Director
Option 8,421 $10.88 $91,620
5 Mar 2019
102,267
1 Aug 2017 Roger C Lucas
Director
Sale 2,250 $10.07 $22,658
1 Aug 2017
93,846
25 May 2017 Roger C Lucas
Director
Option 20,362 $6.97 $141,923
25 May 2017
96,096
1 May 2017 Roger C Lucas
Director
Sale 4,000 $7.31 $29,240
1 May 2017
62,822
1 Feb 2017 Roger C Lucas
Director
Sale 4,000 $7.32 $29,280
1 Feb 2017
66,822
1 Nov 2016 Roger C Lucas
Director
Sale 4,000 $6.10 $24,400
1 Nov 2016
70,822
1 Sep 2016 Roger C Lucas
Director
Sale 4,000 $5.07 $20,280
1 Sep 2016
74,822
21 May 2016 Roger C Lucas
Director
Option 11,795 $4.28 $50,483
21 May 2016
78,822
21 May 2015 Roger C Lucas
Director
Option 27,027 $7.63 $206,216
21 May 2015
67,027
5 Aug 2013 Roger C Lucas
Director
Sale 5,000 $13.42 $67,100
5 Aug 2013
40,000
3 Jul 2013 Roger C Lucas
Director
Sale 5,000 $13.43 $67,150
3 Jul 2013
45,000
3 Jun 2013 Roger C Lucas
Director
Sale 5,000 $13.32 $66,600
3 Jun 2013
50,000
15 May 2013 Roger C Lucas
Director
Sale 5,000 $14.11 $70,550
15 May 2013
55,000
3 Apr 2013 Roger C Lucas
Director
Sale 5,000 $13.49 $67,450
3 Apr 2013
60,000
4 Mar 2013 Roger C Lucas
Director
Sale 5,000 $13.87 $69,350
4 Mar 2013
65,000
7 Feb 2013 Roger C Lucas
Director
Sale 1,143 $11.27 $12,882
7 Feb 2013
70,000
4 Feb 2013 Roger C Lucas
Director
Sale 3,857 $11.52 $44,433
4 Feb 2013
71,143
7 Jan 2013 Roger C Lucas
Director
Sale 3,899 $11.08 $43,201
7 Jan 2013
75,000
3 Jan 2013 Roger C Lucas
Director
Sale 1,101 $11.09 $12,210
3 Jan 2013
78,899
3 Dec 2012 Roger C Lucas
Director
Sale 5,000 $11.96 $59,800
3 Dec 2012
80,000
5 Nov 2012 Roger C Lucas
Director
Sale 5,000 $11.59 $57,950
5 Nov 2012
85,000
4 Oct 2012 Roger C Lucas
Director
Sale 1,893 $11.47 $21,713
4 Oct 2012
90,000
3 Oct 2012 Roger C Lucas
Director
Sale 3,107 $11.38 $35,358
3 Oct 2012
91,893
17 Sep 2012 Roger C Lucas
Director
Sale 5,000 $11.87 $59,350
17 Sep 2012
95,000
10 Oct 2017 Roger C Lucas
Sale 100 $121.96 $12,196
10 Oct 2017
1,870
8 Sep 2017 Roger C Lucas
Sale 100 $120.94 $12,094
8 Sep 2017
1,970
10 Aug 2017 Roger C Lucas
Sale 100 $114.30 $11,430
10 Aug 2017
2,070
10 Jul 2017 Roger C Lucas
Sale 100 $116.86 $11,686
10 Jul 2017
2,170
9 Jun 2017 Roger C Lucas
Sale 100 $113.62 $11,362
9 Jun 2017
2,270
22 May 2017 Roger C Lucas
Sale 1,059 $110.01 $116,501
22 May 2017
2,370
10 May 2017 Roger C Lucas
Sale 100 $110.59 $11,059
10 May 2017
3,429
10 Apr 2017 Roger C Lucas
Sale 100 $101.15 $10,115
10 Apr 2017
3,551
10 Mar 2017 Roger C Lucas
Sale 100 $107.77 $10,777
10 Mar 2017
3,629
10 Feb 2017 Roger C Lucas
Sale 100 $102.60 $10,260
10 Feb 2017
3,729
10 Jan 2017 Roger C Lucas
Sale 100 $103.57 $10,357
10 Jan 2017
3,829
9 Dec 2016 Roger C Lucas
Sale 100 $108.92 $10,892
9 Dec 2016
3,929
16 Nov 2016 Roger C Lucas
Sale 100 $105.75 $10,575
16 Nov 2016
4,029
19 Oct 2016 Roger C Lucas
Sale 100 $104.71 $10,471
19 Oct 2016
3,215
21 Sep 2016 Roger C Lucas
Sale 100 $108.91 $10,891
21 Sep 2016
3,315
17 Aug 2016 Roger C Lucas
Sale 100 $113.70 $11,370
17 Aug 2016
3,415
20 Jul 2016 Roger C Lucas
Sale 100 $111.03 $11,103
20 Jul 2016
3,615
15 Jun 2016 Roger C Lucas
Sale 100 $112.15 $11,215
15 Jun 2016
3,715
15 Jun 2016 Roger C Lucas
Sale 100 $112.15 $11,215
15 Jun 2016
3,715
18 May 2016 Roger C Lucas
Sale 100 $102.53 $10,253
18 May 2016
3,815
18 May 2016 Roger C Lucas
Sale 100 $102.53 $10,253
18 May 2016
3,815
6 May 2016 Roger C Lucas
Sale 500 $100.24 $50,120
6 May 2016
3,915
6 May 2016 Roger C Lucas
Sale 500 $100.24 $50,120
6 May 2016
3,915
20 Apr 2016 Roger C Lucas
Sale 100 $92.40 $9,240
20 Apr 2016
4,315
20 Apr 2016 Roger C Lucas
Sale 100 $92.40 $9,240
20 Apr 2016
4,315
16 Mar 2016 Roger C Lucas
Sale 100 $92.90 $9,290
16 Mar 2016
4,415
16 Mar 2016 Roger C Lucas
Sale 100 $92.90 $9,290
16 Mar 2016
4,415
5 Feb 2016 Roger C Lucas
Option 5,000 $70.35 $351,750
5 Feb 2016
9,515
5 Feb 2016 Roger C Lucas
Option 5,000 $70.35 $351,750
5 Feb 2016
9,515
17 Aug 2015 Roger C Lucas
Option 5,000 $66.90 $334,500
17 Aug 2015
8,456
13 Aug 2015 Roger C Lucas
Option 5,000 $61.46 $307,300
13 Aug 2015
8,456
19 Feb 2014 Roger C Lucas
Option 15,000 $65.03 $975,450
19 Feb 2014
17,456
4 Nov 2013 Roger C Lucas
Option 10,000 $55.43 $554,300
4 Nov 2013
12,456


ChemoCentryx Inc executives and stock owners

ChemoCentryx Inc executives and other stock owners filed with the SEC include: